The Fund aims to maximise long term total return.
Name | % Net Assets |
---|---|
Dunedin Smaller Companies | 4.7% |
British American Tobacco | 4.5% |
Royal Dutch Shell 'B' | 3.8% |
AstraZeneca | 3.6% |
HSBC | 3.6% |
Centrica | 3.5% |
Aviva | 3.1% |
Schroders | 3.1% |
Associated British Foods | 3.0% |
Tesco | 2.9% |
Key | % Net Assets |
---|---|
Dunedin Smaller Companies | 4.7% |
British American Tobacco | 4.5% |
Royal Dutch Shell 'B' | 3.8% |
AstraZeneca | 3.6% |
Other | 83.4% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | n/a |
---|---|
Fund Manager | Pan European Equities Team |
TER | 2.13 (31-Jan-2009) |
Minimum Investment | |
---|---|
Initial | 500 |
Additional | 100 |
Savings | 50 |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.14 |
You are here: research